Physician profile
Sammy Elmariah
NPI 1659350858
$125,856.12
in general payments reported to CMS, 2019-2025
8 companies · $27K in 2025
The $27K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $2,059 · 2021: $11K · 2022: $16K · 2023: $41K · 2024: $27K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $14K · Food and Beverage: $9,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,556.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,800.00 |
| Travel and Lodging | $13,630.12 |
| Food and Beverage | $9,413.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $115,637.10 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $6,115.95 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Harmony |
| Abbott Laboratories | $2,940.84 | 2020-2025 | Triclip, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $629.28 | 2019 | |
| Boston Scientific Corporation | $411.24 | 2019-2023 | Opticross |
| Abiomed | $121.71 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sammy Elmariah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.